Central Pharmaceutical JSC No2 (HSTC:DP2) Stock Based Compensation: ₫0.00 Mil (TTM As of . 20)


HSTC:DP2 Central Pharmaceutical JSC No2 HSTC:DP2
23 GF Score
Price ₫4,900.00
View Full Analysis

What is Central Pharmaceutical JSC No2 Stock Based Compensation?

Central Pharmaceutical JSC No2 HSTC:DP2 +8.89% 23 Stock Based Compensation is ₫0.00 Mil as of . 20. GuruFocus rates HSTC:DP2 with a GF Score™ of 23/100.

Central Pharmaceutical JSC No2's Stock Based Compensation for the six months ended in . 20 was ₫0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2 Stock Based Compensation Related Terms

Central Pharmaceutical JSC No2 Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Central Pharmaceutical JSC No2's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 Stock Based Compensation Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Stock Based Compensation

Central Pharmaceutical JSC No2 Semi-Annual Data
Stock Based Compensation
HSTC:DP2
23GF Score
Central Pharmaceutical JSC No2 HSTC:DP2
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceutical JSC No2 Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

What does a Stock Based Compensation of ₫0.00 Mil mean?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a Stock Based Compensation of ₫0.00 Mil as of . 20. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Central Pharmaceutical JSC No2 and its competitors.
Is Central Pharmaceutical JSC No2's Stock Based Compensation too high?
Central Pharmaceutical JSC No2's current Stock Based Compensation is ₫0.00 Mil. Overall, Central Pharmaceutical JSC No2 has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceutical JSC No2's Stock Based Compensation compare to ?
Central Pharmaceutical JSC No2's Stock Based Compensation of ₫0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Central Pharmaceutical JSC No2 and its competitors. Central Pharmaceutical JSC No2's current Stock Based Compensation is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceutical JSC No2 stock overvalued right now?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a current Stock Based Compensation of ₫0.00 Mil. The current Stock Based Compensation is ₫0.00 Mil. Central Pharmaceutical JSC No2's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Central Pharmaceutical JSC No2 (HSTC:DP2), the current Stock Based Compensation is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Central Pharmaceutical JSC No2 Business Description

Comparable Companies
Address No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.
23GF Score

Get the complete analysis for HSTC:DP2

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫4,900.00
Price